LQDA

Liquidia Corp

Nasdaq · CIK 1819576

Last close28.64
Daily change+0.65 (2.32%)
10 Years gain+158.02%
Dividends TTM0
Dividend yield0.00%

Fundamental Analysis

LQDA · STANDARD

SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231

Screener
Fundamental
82.3
Momentum
100.0
Acceleration
100.0
Confidence
69.0
Annual Revenue7
Quarterly Revenue20
Annual CFO7
Balance SheetAvailable
RankingEligible

Score Breakdown

Growth25.0 / 25
Quality18.2 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5

Signals

Gross margin expansionGross margin improved by 34.9183 percentage points.
Operating leverageOperating margin improved by 879.7028 percentage points.
Net debt reductionNet debt declined versus the comparison period.

Warnings

Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 19.0487%.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.

Key Metrics

Revenue Growth TTM2,489.78%OK
Revenue CAGR 3Y114.98%OK
Gross Margin92.37%OK
Operating Margin30.26%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y41.88%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y19.05%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL

Financial History

PeriodRevenueGross ProfitOperating IncomeCFOFCFGross MarginOp MarginFCF MarginROICShares
2025 FY Dec 31, 2025$158.32M$145.08M-$51.38M-$35.69M-$40.02M91.64%-32.45%-25.28%n/a86.06M
2025 FY Dec 31, 2024$14.00M$8.12M-$121.29M-$93.42M-$98.37M58%-866.63%-702.85%n/a78.71M
2025 FY Dec 31, 2023$17.49M$14.60M-$73.38M-$41.56M-$42.85M83.49%-419.62%-245.05%n/a64.99M
2023 FY Dec 31, 2022$15.94M$13.08M-$38.77M-$28.59M-$29.18M82.06%-243.3%-183.12%-174.03%60.96M
2022 FY Dec 31, 2021$12.85M$9.83M-$33.80M-$34.04M-$34.14M76.48%-262.95%-265.63%-155.94%49.68M

Formula Trace

MetricValueFormulaStatusSource
Revenue TTM$367.72Msum latest 4 fiscal quarters RevenueOK0001104659-26-094410, 0001104659-25-105215
Revenue Growth TTM2,489.78%Revenue_TTM / Revenue_TTM_1Y_ago - 1OK0001104659-26-094410, 0001104659-25-105215
Revenue CAGR 3Y114.98%(Revenue_current / Revenue_3Y_ago)^(1/3) - 1OK0001104659-26-023804
Revenue CAGR 5Y192.49%(Revenue_current / Revenue_5Y_ago)^(1/5) - 1OK0001104659-26-023804
Gross Profit CAGR 3Y123.04%(GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1OK0001104659-26-023804
Operating Income Growthn/aOperatingIncome_current / OperatingIncome_prior_year - 1INSUFFICIENT_HISTORY0001104659-26-094410, 0001104659-25-105215
FCF Growthn/aFCF_current / FCF_prior_year - 1INSUFFICIENT_HISTORYderived
Revenue Growth Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Profit Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Operating Income Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
FCF Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Margin92.37%Gross Profit / RevenueOK0001104659-26-094410, 0001104659-25-105215
Operating Margin30.26%Operating Income / RevenueOK0001104659-26-094410, 0001104659-25-105215
Net Debt / CFOn/aNet Debt / CFONOT_MEANINGFUL0001104659-26-094410
Current Ratio2.31xCurrent Assets / Current LiabilitiesOKderived
Revenue per Diluted Share$3.63Revenue / Diluted SharesOK0001104659-26-094410, 0001104659-25-105215
SBC / FCFn/aSBC / FCFNOT_MEANINGFULderived
Dividend Payout Ration/aCash dividends paid / Net incomeNOT_MEANINGFUL0001104659-26-023804